Imagine you’re researching a story about a new medical device undergoing federal review. You send an email to a source seeking details. But unbeknownst to you, your email has been infected with malware. When your message is opened, the software secretly scours your source’s computer for insider information.
It’s a hypothetical situation – but not far-fetched, says Geoffrey King, a lawyer and lecturer who previously ran the Internet and technology policy program at the Committee to Protect Journalists. Continue reading →
The Food and Drug Administration has banned a communications practice that troubled journalists and sparked protests from AHCJ and others.
The agency has forbidden its media staff from using “close-hold embargoes,” in which reporters receive early access to information provided they promise not to seek comments from others until the embargo lifts, according to a letter sent Thursday to Karl Stark, president of the Association of Health Care Journalists. Continue reading →
AHCJ is protesting the Food and Drug Administration’s recent restrictive practices in handling news embargoes and has asked the agency for clarification of its policies.
In an Oct. 11 letter to Jason Young, the FDA’s acting assistant commissioner for media affairs, AHCJ President Karl Stark raised strong objections to the practice of providing embargoed information on the condition that reporters refrain from seeking outside comment until the embargo lifts. Continue reading →
Health journalists seeking information from government agencies often encounter obstacles, especially at the federal level, according to AHCJ’s recent survey. The biggest roadblocks involve delays, bureaucracy, scripted replies, and barriers to interviews, survey respondents said.
Three-quarters said it is difficult to get the information they need from the federal government, and two-thirds reported difficulty getting adequate responses from state government. Continue reading →